Evidence map›Paper›PMID 10816520›Full record

ArticleInfection and immunity2000

Innate immune responses in children and adults with Shigellosis.

R Raqib, S M Mia, F Qadri, T I Alam, N H Alam, A K Chowdhury, M M Mathan, J Andersson

Abstract readComparative Study
In one paragraph

Article in Infection and immunity, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 62 citations in OpenAlex.

  1. A phase I trial of WRSS1, aHuman vaccines & immunotherapeutics · 2019
    Trial
  2. Sequential invasion of epithelial and immune cells in Shigellosis.bioRxiv : the preprint server for biology · 2026
    Article
  3. Shigellosis.Lancet (London, England) · 2025
    Review
  4. The Modulation of Septic Shock: A Proteomic Approach.International journal of molecular sciences · 2024
    Article
  5. Article
  6. Age-dependent acquisition of IgG antibodies toFrontiers in immunology · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Lewis Blood-group Antigens Are Associated With Altered Susceptibility to Shigellosis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Human vaccines & immunotherapeutics · 2019
    Review
  16. Article
  17. Shigella impairs T lymphocyte dynamics in vivo.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  18. PGE(2) suppression of innate immunity during mucosal bacterial infection.Frontiers in cellular and infection microbiology · 2013
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

R RaqibLaboratory Sciences Division, International Centre for Diarrhoeal Diseases Research, Bangladesh, Dhaka, Bangladesh. rubhana@icddrb.org
S M Mia
F Qadri
T I Alam
N H Alam
A K Chowdhury
M M Mathan
J Andersson
International Centre for Diarrhoeal Disease Research · BDKarolinska University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An array of pro- and anti-inflammatory mediators of the innate immune system was analyzed in stool, urine, and rectal mucosa samples from adults and children with shigellosis to better understand their role in recovery from and in the immunopathogenesis of the disease. Increased concentrations of lactoferrin (Lf), myeloperoxidase (MPO), prostaglandin E(2), and leukotriene B(4) (LTB(4)) in stool during acute shigellosis in both children and adults indicated that activated cells of the innate defense system at the mucosal site were secreting the mediators. Increased concentration of MPO and 8-iso-prostaglandin F(2alpha) and lower levels of superoxide dismutase (SOD) activity in stool during acute Shigella infection suggested increased formation of reactive oxygen species, free radical-catalyzed peroxidation of membrane lipids, and decreased scavenging of the reactive oxygen radicals. In children, lower expression of SOD in tissue with severe inflammation and lower levels of SOD activity in stool for longer periods compared to adults may further worsen the tissue damage and predispose the children to a lowered defense. Both adult and pediatric patients had significantly higher expression of inducible nitric oxide synthase (iNOS) in the rectum with severe inflammation, compared to that seen with mild inflammation, accompanied by persistently up-regulated iNOS mRNA, reflecting increased production of nitric oxide at the local site. However, in contrast to adults, reduced urinary nitrate levels in pediatric patients during acute shigellosis suggested lower production of nitric oxide in the renal compartment. Persistent production of Lf in pediatric patients may contribute to chronic inflammation in the rectum. In addition, increased production of proinflammatory mediators in the rectum of patients with severe histology suggested contribution of these molecules to the immunopathogenesis of severe colitis caused by shigellae.

Indexed as

Acute DiseaseAdolescentAdultAge FactorsAnti-Inflammatory AgentsChildChild, PreschoolColitisConvalescenceCyclooxygenase 2Dysentery, BacillaryFecesHumansImmunity, InnateInflammation MediatorsIsoenzymesAnti-Inflammatory AgentsCyclooxygenase 2Inflammation MediatorsIsoenzymesLeukotrienesMembrane ProteinsNitratesNitric Oxide SynthaseNitric Oxide Synthase Type IINitritesNOS2 protein, humanPeroxidaseProstaglandin-Endoperoxide SynthasesProstaglandinsPTGS2 protein, humanRNA, MessengerSuperoxide Dismutase

Identifiers

PMID10816520
PMCPMC97651
OpenAlexW2057939715

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.